Sept 11 (Reuters) - Imv Inc IMV.TO :
* IMV INC. ANNOUNCES PHASE 2 BASKET TRIAL IN COLLABORATION WITH MERCK TO EVALUATE DPX-SURVIVAC IN COMBINATION WITH KEYTRUDA® ACROSS FIVE SOLID TUMOR INDICATIONS
* IMV INC - EXPECTS TO INITIATE TRIAL ENROLLMENT IN 4TH QUARTER OF 2018